Financial Consulate’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527 Buy
+1
New +$561 ﹤0.01% 1327
2022
Q3
Sell
-572
Closed -$201K 121
2022
Q2
$201K Buy
+572
New +$233K 0.09% 119
2022
Q1
Sell
-305
Closed -$201K 138
2021
Q4
$201K Buy
+305
New +$191K 0.07% 135
2021
Q3
Sell
-326
Closed -$206K 134
2021
Q2
$206K Buy
+326
New +$180K 0.07% 126

Other funds holding IDXX

Financial Consulate's IDXX Position: Q2 2026 in Review

Financial Consulate opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1 share worth $527. The stake represents ﹤0.01% of the portfolio and ranks #1327 among its holdings. This is a return to the name: Financial Consulate previously reported a position in IDXX as recently as Q2 2022.

Financial Consulate first reported a position in IDXX in Q2 2021 and has held it in 4 quarters since. The position peaked at $206K in Q2 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Financial Consulate held 1 share of Idexx Laboratories worth $527 as of Q2 2026.
  • Idexx Laboratories was a new Financial Consulate position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #1327 holding.
  • Financial Consulate first reported a position in Idexx Laboratories in Q2 2021 and has held it in 4 quarters since.
  • Financial Consulate's Idexx Laboratories position peaked at $206K in Q2 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.